How I treat infant leukemia
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
How I treat infant leukemia
P Brown, R Pieters, A Biondi - Blood, 2019 - pure.johnshopkins.edu
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
How I treat infant leukemia.
P Brown, R Pieters, A Biondi - Blood, 2018 - europepmc.org
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
How I treat infant leukemia
P Brown, R Pieters, A Biondi - 2019 - pubmed.ncbi.nlm.nih.gov
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
[HTML][HTML] How I treat infant leukemia
P Brown, R Pieters, A Biondi - Blood, 2019 - Elsevier
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
How I treat infant leukemia
P Brown, R Pieters, A Biondi - BLOOD, 2019 - boa.unimib.it
Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …
presentation in a uniquely vulnerable host, its poor response to current therapies, and its …